Market Tracker

11/21 1:55pm ET
5.18
Real-Time Quote
 +0.135 / +2.68%
Today’s Change
3.17
Today|||52-Week Range
6.95
+1.07%
Year-to-Date

Today’s Trading

Previous close5.04
Today’s open5.12
Day’s range5.00 - 5.21
Volume1,766,507
Average volume (3 months)3,836,436
Market cap$1.2B
Dividend yield--
Data as of 1:40pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)-40.91%
Earnings growth (this year)-0.72%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-5.26%
P/E ratioNM
Price/Sales41.53
Price/Book4.97

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc-0.75-1.77%
HALOHalozyme Therapeutic...+0.08+0.95%
OPHTOphthotech Corp+0.47+1.16%
IMGNImmunoGen Inc+0.21+2.17%
Data as of 1:55pm ET, 11/21/2014

Financials

Last reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$20.9M
Annual profit (last year)-$52.0M
Net profit margin-248.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts